The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Letter/Comment
On November 21, 2013, AHRMM submitted electronically
Advisory
An overview of the Centers for Medicare & Medicaid Services' three final rules for calendar year 2011 the outpatient prospective payment
Magazine & Journal Articles
Managing contract pricing more effectively—from creation to renewal or expiration—can deliver real operational and financial benefits for hea
Advisory
The Patient Protection and Affordable Care Act of 2010 (ACA) requires the Secretary of Health and Human Services to establish a VBP program t
Magazine & Journal Articles
In this page, AHRMM recommends these 3 proactive activities in the event of economic downturn.
Advisory
New Guidance on Humidity Levels in the Operating Room